Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michael Kattan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Disease Progression

Anatomy

Prostate

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Stephenson Andrew J; Wood David P; Kattan Michael W; Klein Eric A; Scardino Peter T; Eastham James A; Carver Brett S
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
Kattan Michael W
Editorial comment.
Stephenson Andrew J; Kattan Michael W; Eastham James A; Bianco Fernando J; Yossepowitch Ofer; Vickers Andrew J; Klein Eric A; Wood David P; Scardino Peter T
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Kattan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Stephenson Andrew J; Wood David P; Kattan Michael W; Klein Eric A; Scardino Peter T; Eastham James A; Carver Brett S
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
The Journal of urology 2009;182(4):1357-63.
2009: Kattan Michael W
Editorial comment.
Urology 2009;74(3):664.
2009: Stephenson Andrew J; Kattan Michael W; Eastham James A; Bianco Fernando J; Yossepowitch Ofer; Vickers Andrew J; Klein Eric A; Wood David P; Scardino Peter T
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4300-5.
2009: Kattan Michael W
Prediction models for transitional cell carcinoma.
The Journal of urology 2009;182(2):423-4.
2009: Fuchsjäger Michael H; Shukla-Dave Amita; Hricak Hedvig; Wang Liang; Touijer Karim; Donohue John F; Eastham James A; Kattan Michael W
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
BJU international 2009;104(3):315-20.
2009: Nguyen Carvell T; Kattan Michael W
Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
Cancer 2009;115(13 Suppl):3039-45.
2009: Nguyen Carvell T; Zelefsky Michael J; Kattan Michael W
The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
Cancer 2009;115(13 Suppl):3121-7.
2009: Kudahetti Sak; Fisher Gabrielle; Ambroisine Laurence; Foster Christopher; Reuter Victor; Eastham James; Møller Henrik; Kattan Michael W; Cooper Colin S; Scardino Peter; Cuzick Jack; Berney Daniel M
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.
BJU international 2009;104(1):20-4.
2009: Pantalone Kevin M; Kattan Michael W; Yu Changhong; Wells Brian J; Arrigain Susana; Jain Anil; Atreja Ashish; Zimmerman Robert S
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
Acta diabetologica 2009;46(2):145-54.
2009: Ficarra Vincenzo; Novara G; Boscolo-Berto R; Artibani W; Kattan M W
How accurate are present risk group assignment tools in penile cancer?
World journal of urology 2009;27(2):155-60.
2009: Berney D M; Gopalan A; Kudahetti S; Fisher G; Ambroisine L; Foster C S; Reuter V; Eastham J; Moller H; Kattan M W; Gerald W; Cooper C; Scardino P; Cuzick J
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.
British journal of cancer 2009;100(6):888-93.
2009: Tiong H Y; Goldfarb D A; Kattan M W; Alster J M; Thuita L; Yu C; Wee A; Poggio E D
Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry.
The Journal of urology 2009;181(3):1248-55.
2009: Kattan Michael W; Vickers Andrew J; Yu Changhong; Bianco Fernando J; Cronin Angel M; Eastham James A; Klein Eric A; Reuther Alwyn M; Edson Pontes Jose; Scardino Peter T
Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.
Cancer 2009;115(5):1005-10.
2009: Valdagni Riccardo; Scardino Peter T; Denis Louis; Kattan Michael W
Predictive modeling in prostate cancer: a conference summary.
European urology 2009;55(2):300-2.
2009: Stone Nelson N; Potters Louis; Davis Brian J; Ciezki Jay P; Zelefsky Michael J; Roach Mack; Shinohara Katsuto; Fearn Paul A; Kattan Michael W; Stock Richard G
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2009;73(2):341-6.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Roehrborn Claus G; Kattan Michael W
An updated catalog of prostate cancer predictive tools.
Cancer 2008;113(11):3075-99.
2008: Wells Brian J; Jain Anil; Arrigain Susana; Yu Changhong; Rosenkrans Wayne A; Kattan Michael W
Predicting 6-year mortality risk in patients with type 2 diabetes.
Diabetes care 2008;31(12):2301-6.
2008: Lane Brian R; Kattan Michael W
Prognostic models and algorithms in renal cell carcinoma.
The Urologic clinics of North America 2008;35(4):613-25; vii.
2008: Gross Neil D; Patel Snehal G; Carvalho Andre L; Chu Pen-Yuan; Kowalski Luis P; Boyle Jay O; Shah Jatin P; Kattan Michael W
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.
Head & neck 2008;30(10):1352-60.
2008: Motzer Robert J; Bukowski Ronald M; Figlin Robert A; Hutson Thomas E; Michaelson M Dror; Kim Sindy T; Baum Charles M; Kattan Michael W
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
Cancer 2008;113(7):1552-8.
2008: Fu Alex Z; Kattan Michael W
Utilities should not be multiplied: evidence from the preference-based scores in the United States.
Medical care 2008;46(9):984-90.
2008: Kattan Michael W
Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
European urology 2008;54(3):611.
2008: Vickers Andrew J; Basch Ethan; Kattan Michael W
Against diagnosis.
Annals of internal medicine 2008;149(3):200-3.
2008: Kattan Michael W
Should I use this nomogram?
BJU international 2008;102(4):421-2.
2008: Schröder Fritz; Kattan Michael W
The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.
European urology 2008;54(2):274-90.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Suardi Nazareno; Kattan Michael W
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(14):4400-7.
2008: Hernandez Adrian V; Walker Esteban; Ioannidis John P A; Kattan Michael W
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
American heart journal 2008;156(1):23-30.
2008: Kattan Michael W
Do we need more nomograms for predicting outcomes in patients with prostate cancer?
Nature clinical practice. Urology 2008;5(7):366-7.
2008: Dong Fei; Kattan Michael W; Steyerberg Ewout W; Jones J Stephen; Stephenson Andrew J; Schröder Fritz H; Klein Eric A
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
The Journal of urology 2008;180(1):150-4; discussion 154.
2008: Walker Esteban; Hernandez Adrian V; Kattan Michael W
Meta-analysis: Its strengths and limitations.
Cleveland Clinic journal of medicine 2008;75(6):431-9.
2008: Arlen Philip M; Bianco Fernando; Dahut William L; D'Amico Anthony; Figg William D; Freedland Stephen J; Gulley James L; Kantoff Philip W; Kattan Michael W; Lee Andrew; Regan Meredith M; Sartor Oliver;
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
The Journal of urology 2008;179(6):2181-5; discussion 2185-6.
2008: Raj Ganesh V; Thompson R Houston; Leibovich Bradley C; Blute Michael L; Russo Paul; Kattan Michael W
Preoperative nomogram predicting 12-year probability of metastatic renal cancer.
The Journal of urology 2008;179(6):2146-51; discussion 2151.
2008: Klein Eric A; Bianco Fernando J; Serio Angel M; Eastham James A; Kattan Michael W; Pontes J Edson; Vickers Andrew J; Scardino Peter T
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
The Journal of urology 2008;179(6):2212-6; discussion 2216-7.
2008: Eastham James A; Scardino Peter T; Kattan Michael W
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
The Journal of urology 2008;179(6):2207-10; discussion 2210-1.
2008: Kattan Michael W; Gönen Mithat
The prediction philosophy in statistics.
Urologic oncology 2008;26(3):316-9.
2008: Swindle Peter; Eastham James A; Ohori Makoto; Kattan Michael W; Wheeler Thomas; Maru Norio; Slawin Kevin; Scardino Peter T
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2008;179(5 Suppl):S47-51.
2008: Shariat Shahrokh F; Karakiewicz Pierre I; Margulis Vitaly; Kattan Michael W
Inventory of prostate cancer predictive tools.
Current opinion in urology 2008;18(3):279-96.
2008: Kattan Michael W
Predicting prostate cancer behavior--what is a urologist to do?
The Journal of urology 2008;179(5):1658-9.
2008: Vickers Andrew J; Bianco Fernando J; Gonen Mithat; Cronin Angel M; Eastham James A; Schrag Deborah; Klein Eric A; Reuther Alwyn M; Kattan Michael W; Pontes J Edson; Scardino Peter T
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
European urology 2008;53(5):960-6.
2008: Karakiewicz Pierre I; Bhojani Naeem; Neugut Alfred; Shariat Shahrokh F; Jeldres Claudio; Graefen Markus; Perrotte Paul; Peloquin Francois; Kattan Michael W
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Vickers Andrew J; Jang Kwang; Sargent Daniel; Lilja Hans; Kattan Michael W
Systematic review of statistical methods used in molecular marker studies in cancer.
Cancer 2008;112(8):1862-8.
2008: Kattan Michael W
Nomograms are difficult to beat.
European urology 2008;53(4):671-2.
2008: Richstone Lee; Bianco Fernando J; Shah Hiral H; Kattan Michael W; Eastham James A; Scardino Peter T; Scherr Douglas S
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU international 2008;101(5):541-6.
2008: Kattan Michael W
A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy.
Nature clinical practice. Urology 2008;5(3):138-9.
2008: Cho Clifford S; Gonen Mithat; Shia Jinru; Kattan Michael W; Klimstra David S; Jarnagin William R; D'Angelica Michael I; Blumgart Leslie H; DeMatteo Ronald P
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
Journal of the American College of Surgeons 2008;206(2):281-91.
2008: Kattan Michael W; Gönen Mithat; Jarnagin William R; DeMatteo Ronald; D'Angelica Michael; Weiser Martin; Blumgart Leslie H; Fong Yuman
A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer.
Annals of surgery 2008;247(2):282-7.
2008: Eastham James A; Kattan Michael W; Fearn Paul; Fisher Gabrielle; Berney Daniel M; Oliver Tim; Foster Christopher S; Møller Henrik; Reuter Victor; Cuzick Jack; Scardino Peter;
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
European urology 2008;53(2):347-54.
2008: Heath Elisabeth I; Kattan Michael W; Powell Isaac J; Sakr Wael; Brand Timothy C; Rybicki Benjamin A; Thompson Ian M; Aronson William J; Terris Martha K; Kane Christopher J; Presti Joseph C; Amling Christopher L; Freedland Stephen J
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
Urology 2008;71(1):151-5.
2008: Weiser Martin R; Landmann Ron G; Kattan Michael W; Gonen Mithat; Shia Jinru; Chou Joanne; Paty Philip B; Guillem José G; Temple Larissa K; Schrag Deborah; Saltz Leonard B; Wong W Douglas
Individualized prediction of colon cancer recurrence using a nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):380-5.
2008: Kattan Michael W; Cuzick Jack; Fisher Gabrielle; Berney Daniel M; Oliver Tim; Foster Christopher S; Møller Henrik; Reuter Victor; Fearn Paul; Eastham James; Scardino Peter T;
Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.
Cancer 2008;112(1):69-74.
2008: Chi Dennis S; Palayekar Meena J; Sonoda Yukio; Abu-Rustum Nadeem R; Awtrey Christopher S; Huh Jae; Eisenhauer Eric L; Barakat Richard R; Kattan Michael W
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
Gynecologic oncology 2008;108(1):191-4.
2008: Klein Eric A; Kattan Michael; Stephenson Andrew; Vickers Andrew
How many lymphadenectomies does it take to cure one patient?
European urology 2008;53(1):13-5; discussion 18-20.
2008: Orthuber Wolfgang; Fiedler Gunar; Kattan Michael; Sommer Thorsten; Fischer-Brandies Helge
Design of a Global Medical Database which is Searchable by Human Diagnostic Patterns.
The open medical informatics journal 2008;2():21-31.
2007: Lauer Michael S; Pothier Claire E; Magid David J; Smith S Scott; Kattan Michael W
An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.
Annals of internal medicine 2007;147(12):821-8.
2007: Kattan Michael W; Scardino Peter T
Evidence for the usefulness of nomograms.
Nature clinical practice. Urology 2007;4(12):638-9.
2007: Berney Daniel M; Fisher Gabrielle; Kattan Michael W; Oliver R Timothy D; Møller Henrik; Fearn Paul; Eastham James; Scardino Peter; Cuzick Jack; Reuter Victor E; Foster Christopher S;
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
BJU international 2007;100(6):1240-4.
2007: Stone Nelson N; Potters Louis; Davis Brian J; Ciezki Jay P; Zelefsky Michael J; Roach Mack; Fearn Paul A; Kattan Michael W; Stock Richard G
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
International journal of radiation oncology, biology, physics 2007;69(5):1472-7.
2007: Kattan Michael W
Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
European urology 2007;52(5):1528.
2007: Kattan Michael W
Should physicians use the updated Partin tables to predict pathologic stage in patients with prostate cancer?
Nature clinical practice. Urology 2007;4(11):592-3.
2007: Roemeling Stijn; Roobol Monique J; Kattan Michael W; van der Kwast Theo H; Steyerberg Ewout W; Schröder Fritz H
Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
Cancer 2007;110(10):2218-21.
2007: Eilber Frederick C; Kattan Michael W
Sarcoma nomogram: validation and a model to evaluate impact of therapy.
Journal of the American College of Surgeons 2007;205(4 Suppl):S90-5.
2007: Berney D M; Fisher G; Kattan M W; Oliver R T D; Møller H; Fearn P; Eastham J; Scardino P; Cuzick J; Reuter V E; Foster C S;
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome.
Histopathology 2007;51(4):452-7.
2007: Lucia M Scott; Epstein Jonathan I; Goodman Phyllis J; Darke Amy K; Reuter Victor E; Civantos Francisco; Tangen Catherine M; Parnes Howard L; Lippman Scott M; La Rosa Francisco G; Kattan Michael W; Crawford E David; Ford Leslie G; Coltman Charles A; Thompson Ian M
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
Journal of the National Cancer Institute 2007;99(18):1375-83.
2007: Zelefsky Michael J; Kattan Michael W; Fearn Paul; Fearon Bertha L; Stasi Jason P; Shippy Alison M; Scardino Peter T
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
Urology 2007;70(2):283-7.
2007: Nam Robert K; Toi Ants; Klotz Laurence H; Trachtenberg John; Jewett Michael A S; Appu Sree; Loblaw D Andrew; Sugar Linda; Narod Steven A; Kattan Michael W
Assessing individual risk for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3582-8.
2007: Bevilacqua José Luiz B; Kattan Michael W; Fey Jane V; Cody Hiram S; Borgen Patrick I; Van Zee Kimberly J
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3670-9.
2007: Vickers Andrew J; Bianco Fernando J; Serio Angel M; Eastham James A; Schrag Deborah; Klein Eric A; Reuther Alwyn M; Kattan Michael W; Pontes J Edson; Scardino Peter T
The surgical learning curve for prostate cancer control after radical prostatectomy.
Journal of the National Cancer Institute 2007;99(15):1171-7.
2007: Lane Brian R; Babineau Denise; Kattan Michael W; Novick Andrew C; Gill Inderbir S; Zhou Ming; Weight Christopher J; Campbell Steven C
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
The Journal of urology 2007;178(2):429-34.
2007: Van Zee Kimberly J; Kattan Michael W
Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.
Annals of surgical oncology 2007;14(8):2177-8.
2007: Heller Glenn; Kattan Michael W; Scher Howard I
Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.
Medical decision making : an international journal of the Society for Medical Decision Making 2007;27(4):380-6.
2007: Gill Inderbir S; Kavoussi Louis R; Lane Brian R; Blute Michael L; Babineau Denise; Colombo J Roberto; Frank Igor; Permpongkosol Sompol; Weight Christopher J; Kaouk Jihad H; Kattan Michael W; Novick Andrew C
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.
The Journal of urology 2007;178(1):41-6.
2007: Cordon-Cardo Carlos; Kotsianti Angeliki; Verbel David A; Teverovskiy Mikhail; Capodieci Paola; Hamann Stefan; Jeffers Yusuf; Clayton Mark; Elkhettabi Faysal; Khan Faisal M; Sapir Marina; Bayer-Zubek Valentina; Vengrenyuk Yevgen; Fogarsi Stephen; Saidi Olivier; Reuter Victor E; Scher Howard I; Kattan Michael W; Bianco Fernando J; Wheeler Thomas M; Ayala Gustavo E; Scardino Peter T; Donovan Michael J
Improved prediction of prostate cancer recurrence through systems pathology.
The Journal of clinical investigation 2007;117(7):1876-83.
2007: Stephenson Andrew J; Scardino Peter T; Kattan Michael W; Pisansky Thomas M; Slawin Kevin M; Klein Eric A; Anscher Mitchell S; Michalski Jeff M; Sandler Howard M; Lin Daniel W; Forman Jeffrey D; Zelefsky Michael J; Kestin Larry L; Roehrborn Claus G; Catton Charles N; DeWeese Theodore L; Liauw Stanley L; Valicenti Richard K; Kuban Deborah A; Pollack Alan
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2035-41.
2007: Kibel Adam S; Rosenbaum Eli; Kattan Michael W; Picus Joel; Dreicer Robert; Klein Eric A; Chatta Gurkamal S; Nelson Joel B; DiPaola Robert S; Roth Bruce J; Cookson Michael S; Wilding George; Jarrard David F; Beer Tomasz M; Ryan Christopher W; Petrylak Daniel P; Benson Mitchell C; Partin Alan W; Garrett-Mayer Elizabeth; Eisenberger Mario A
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
The Journal of urology 2007;177(5):1777-81.
2007: Chun Felix K-H; Graefen Markus; Briganti Alberto; Gallina Andrea; Hopp Julia; Kattan Michael W; Huland Hartwig; Karakiewicz Pierre I
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
European urology 2007;51(5):1236-40; discussion 1241-3.
2007: Golshayan Ali-Reza; Jin Tao; Maciejewski Jaroslaw; Fu Alex Z; Bershadsky Boris; Kattan Michael W; Kalaycio Matt E; Sekeres Mikkael A
Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.
British journal of haematology 2007;137(2):125-32.
2007: Chun Felix K-H; Karakiewicz Pierre I; Briganti Alberto; Walz Jochen; Kattan Michael W; Huland Hartwig; Graefen Markus
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
BJU international 2007;99(4):794-800.
2007: Shukla-Dave Amita; Hricak Hedvig; Kattan Michael W; Pucar Darko; Kuroiwa Kentaro; Chen Hui-Ni; Spector Jessica; Koutcher Jason A; Zakian Kristen L; Scardino Peter T
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
BJU international 2007;99(4):786-93.
2007: Steuber Thomas; Vickers Andrew; Haese Alexander; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
International journal of cancer. Journal international du cancer 2007;120(7):1499-504.
2007: Baccala Angelo; Reuther Alwyn M; Bianco Fernando J; Scardino Peter T; Kattan Michael W; Klein Eric A
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
Urology 2007;69(3):536-40.
2007: Sekeres Mikkael A; Fu Alex Z; Maciejewski Jaroslaw P; Golshayan Ali-Reza; Kalaycio Matt E; Kattan Michael W
A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
Cancer 2007;109(6):1125-32.
2007: Bianco Fernando J; Mallah Kozhaya N; Korets Ruslan; Hricak Hedvig; Scardino Peter T; Kattan Michael W
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
Urology 2007;69(2):343-6.
2007: Agus David B; Sweeney Christopher J; Morris Michael J; Mendelson David S; McNeel Douglas G; Ahmann Frederick R; Wang Jin; Derynck Mika K; Ng Kimmie; Lyons Benjamin; Allison David E; Kattan Michael W; Scher Howard I
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):675-81.
2007: Steyerberg E W; Roobol M J; Kattan M W; van der Kwast T H; de Koning H J; Schröder F H
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.
The Journal of urology 2007;177(1):107-12; discussion 112.
2007: Wang Liang; Hricak Hedvig; Kattan Michael W; Chen Hui Ni; Kuroiwa Kentaro; Eisenberg Halley F; Scardino Peter T
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
Radiology 2007;242(1):182-8.
2007: Vickers Andrew J; Kattan Michael W; Daniel Sargent
Method for evaluating prediction models that apply the results of randomized trials to individual patients.
Trials 2007;8():14.
2006: Fu Alex Z; Kattan Michael W
Racial and ethnic differences in preference-based health status measure.
Current medical research and opinion 2006;22(12):2439-48.
2006: Snyder Mark E; Bach Ariadne; Kattan Michael W; Raj Ganesh V; Reuter Victor E; Russo Paul
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.
The Journal of urology 2006;176(6 Pt 1):2391-5; discussion 2395-6.
2006: Roach Mack; Weinberg V; Nash M; Sandler H M; McLaughlin P W; Kattan M W
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
The Journal of urology 2006;176(6 Pt 2):S16-20.
2006: Kattan Michael W
Validating a prognostic model.
Cancer 2006;107(11):2523-4.
2006: Cuzick J; Fisher G; Kattan M W; Berney D; Oliver T; Foster C S; Møller H; Reuter V; Fearn P; Eastham J; Scardino P;
Long-term outcome among men with conservatively treated localised prostate cancer.
British journal of cancer 2006;95(9):1186-94.
2006: White Rebekah R; Kattan Michael W; Haney John C; Clary Bryan M; Pappas Theodore N; Tyler Douglas S; Brennan Murray F
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
Annals of surgical oncology 2006;13(11):1485-92.
2006: Chun Felix K-H; Karakiewicz Pierre I; Briganti Alberto; Gallina Andrea; Kattan Michael W; Montorsi Francesco; Huland Hartwig; Graefen Markus
Prostate cancer nomograms: an update.
European urology 2006;50(5):914-26; discussion 926.
2006: Dalal Kimberly Moore; Kattan Michael W; Antonescu Cristina R; Brennan Murray F; Singer Samuel
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Annals of surgery 2006;244(3):381-91.
2006: Stephenson Andrew J; Kattan Michael W; Eastham James A; Dotan Zohar A; Bianco Fernando J; Lilja Hans; Scardino Peter T
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3973-8.
2006: Elkin Elena B; Vickers Andrew J; Kattan Michael W
Primer: using decision analysis to improve clinical decision making in urology.
Nature clinical practice. Urology 2006;3(8):439-48.
2006: Bochner Bernard H; Kattan Michael W; Vora Kinjal C
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3967-72.
2006: Sorbellini Maximiliano; Kattan Michael W; Snyder Mark E; Hakimi A Ari; Sarasohn Debra M; Russo Paul
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy.
The Journal of urology 2006;176(2):472-6; discussion 476.
2006: Schachter Lee R; Bach Ariadne M; Snyder Mark E; Kattan Michael W; Russo Paul
The impact of tumour location on the histological subtype of renal cortical tumours.
BJU international 2006;98(1):63-6.
2006: Stephenson Andrew J; Kattan Michael W
Nomograms for prostate cancer.
BJU international 2006;98(1):39-46.
2006: Ramirez Alvaro; Benayoun Serge; Briganti Alberto; Chun Jongi; Perrotte Paul; Kattan Michael W; Graefen Markus; McCormack Michael; Neugut Alfred I; Saad Fred; Karakiewicz Pierre I
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
European urology 2006;50(1):58-62; discussion 62-3.
2006: Mottet Nicolas; Prayer-Galetti Tommaso; Hammerer Peter; Kattan Michael W; Tunn Ulf
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.
BJU international 2006;98(1):20-7.
2006: Hammerer Peter G; Kattan Michael W; Mottet Nicolas; Prayer-Galetti Tommaso
Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.
BJU international 2006;98(1):11-9.
2006: Kattan Michael W; Ficarra Vincenzo; Artibani Walter; Cunico Sergio Cosciani; Fandella Andrea; Martignoni Guido; Novara Giacomo; Galetti Tommaso Prayer; Zattoni Filiberto;
Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis.
The Journal of urology 2006;175(6):2103-8; discussion 2108.
2006: Teh Bin S; Bastasch Michael D; Mai Wei-Yuan; Kattan Michael W; Butler E Brian; Kadmon Dov
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
The Journal of urology 2006;175(6):2097-101; discussion 2101-2.
2006: Stephenson Andrew J; Scardino Peter T; Eastham James A; Bianco Fernando J; Dotan Zohar A; Fearn Paul A; Kattan Michael W
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of the National Cancer Institute 2006;98(10):715-7.
2006: Ficarra Vincenzo; Zattoni Filiberto; Artibani Walter; Fandella Andrea; Martignoni Guido; Novara Giacomo; Galetti Tommaso Prayer; Zambolin Tiziano; Kattan Michael W;
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.
The Journal of urology 2006;175(5):1700-4; discussion 1704-5.
2006: Hixson Eric D; Kattan Michael W
Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes.
European urology 2006;49(4):600-3.
2006: Wang Liang; Hricak Hedvig; Kattan Michael W; Schwartz Lawrence H; Eberhardt Steven C; Chen Hui-Ni; Scardino Peter T
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
AJR. American journal of roentgenology 2006;186(3):743-8.
2006: Lopez-Corona Ernesto; Ohori Makoto; Wheeler Thomas M; Reuter Victor E; Scardino Peter T; Kattan Michael W; Eastham James A
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
The Journal of urology 2006;175(3 Pt 1):923-7; discussion 927-8.
2006: Steuber Thomas; Vickers Andrew J; Haese Alexander; Becker Charlotte; Pettersson Kim; Chun Felix K-H; Kattan Michael W; Eastham James A; Scardino Peter T; Huland Hartwig; Lilja Hans
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
International journal of cancer. Journal international du cancer 2006;118(5):1234-40.
2006: Kattan Michael W
Measuring hot flashes in men treated with hormone ablation therapy: an unmet need.
Urologic nursing : official journal of the American Urological Association Allied 2006;26(1):13-8.
2006: Wang Liang; Hricak Hedvig; Kattan Michael W; Chen Hui-Ni; Scardino Peter T; Kuroiwa Kentaro
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
Radiology 2006;238(2):597-603.
2006: Slawin Kevin M; Kattan Michael W; Roehrborn Claus G; Wilson Timothy
Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.
Urology 2006;67(1):84-8.
2006: Cowen Mark E; Halasyamani Lakshmi K; Kattan Michael W
Predicting life expectancy in men with clinically localized prostate cancer.
The Journal of urology 2006;175(1):99-103.
2006: Novotny Alexander R; Schuhmacher Christoph; Busch Raymonde; Kattan Michael W; Brennan Murray F; Siewert Jörg Rüdiger
Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.
Annals of surgery 2006;243(1):74-81.
2005: Tsuboi Toshiki; Ohori Makoto; Kuroiwa Kentaro; Reuter Victor E; Kattan Michael W; Eastham James A; Scardino Peter T
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
Urology 2005;66(6):1287-91.
2005: Karakiewicz Pierre I; Eastham James A; Graefen Markus; Cagiannos Ilias; Stricker Phillip D; Klein Eric; Cangiano Thomas; Schröder Fritz H; Scardino Peter T; Kattan Michael W
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
Urology 2005;66(6):1245-50.
2005: Mullerad Michael; Hricak Hedvig; Kuroiwa Kentaro; Pucar Darko; Chen Hui-Ni; Kattan Michael W; Scardino Peter T
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
The Journal of urology 2005;174(6):2158-63.
2005: Ferrone Cristina R; Kattan Michael W; Tomlinson James S; Thayer Sarah P; Brennan Murray F; Warshaw Andrew L
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7529-35.
2005: Katz Ethan M; Kattan Michael W
How to judge a tumor marker.
Nature clinical practice. Oncology 2005;2(10):482-3.
2005: Stephenson Andrew J; Scardino Peter T; Eastham James A; Bianco Fernando J; Dotan Zohar A; DiBlasio Christopher J; Reuther Alwyn; Klein Eric A; Kattan Michael W
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7005-12.
2005: Befort Christie A; Zelefsky Michael J; Scardino Peter T; Borrayo Evelinn; Giesler R Brian; Kattan Michael W
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
Clinical prostate cancer 2005;4(2):100-8.
2005: Swindle Peter; Eastham James A; Ohori Makoto; Kattan Michael W; Wheeler Thomas; Maru Norio; Slawin Kevin; Scardino Peter T
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2005;174(3):903-7.
2005: Lane Brian R; Kattan Michael W
Predicting outcomes in renal cell carcinoma.
Current opinion in urology 2005;15(5):289-97.
2005: Specht Michelle C; Kattan Michael W; Gonen Mithat; Fey Jane; Van Zee Kimberly J
Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
Annals of surgical oncology 2005;12(8):654-9.
2005: Mullerad Michael; Bochner Bernard H; Adusumilli Prasad S; Bhargava Amit; Kikuchi Eiji; Hui-Ni Chen; Kattan Michael W; Chou Ting-Chao; Fong Yuman
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.
The Journal of urology 2005;174(2):741-6.
2005: Stephenson Andrew J; Smith Alex; Kattan Michael W; Satagopan Jaya; Reuter Victor E; Scardino Peter T; Gerald William L
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
Cancer 2005;104(2):290-8.
2005: Saranchuk Jeffery W; Kattan Michael W; Elkin Elena; Touijer A Karim; Scardino Peter T; Eastham James A
Achieving optimal outcomes after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4146-51.
2005: Bianco Fernando J; Riedel Elyn R; Begg Colin B; Kattan Michael W; Scardino Peter T
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.
The Journal of urology 2005;173(6):2099-103.
2005: Isom-Batz Ginger; Bianco Fernando J; Kattan Michael W; Mulhall John P; Lilja Hans; Eastham James A
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
The Journal of urology 2005;173(6):1935-7.
2005: Karakiewicz Pierre I; Benayoun Serge; Kattan Michael W; Perrotte Paul; Valiquette Luc; Scardino Peter T; Cagiannos Ilias; Heinzer Hans; Tanguay Simon; Aprikian Armen G; Huland Hartwig; Graefen Markus
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Mallah Kozhaya N; DiBlasio Christopher J; Rhee Audrey C; Scardino Peter T; Kattan Michael W
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.
Cancer 2005;103(10):2030-4.
2005: Kattan Michael W
When and how to use informatics tools in caring for urologic patients.
Nature clinical practice. Urology 2005;2(4):183-90.
2005: Stephenson Andrew J; Bosl George J; Motzer Robert J; Kattan Michael W; Stasi Jason; Bajorin Dean F; Sheinfeld Joel
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2781-8.
2005: Wong Sandra L; Kattan Michael W; McMasters Kelly M; Coit Daniel G
A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
Annals of surgical oncology 2005;12(4):282-8.
2005: Steuber Thomas; Niemela Pauliina; Haese Alexander; Pettersson Kim; Erbersdobler Andreas; Felix Chun K-H; Graefen Markus; Kattan Michael W; Huland Hartwig; Lilja Hans
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
The Prostate 2005;63(1):13-8.
2005: Dotan Zohar A; Bianco Fernando J; Rabbani Farhang; Eastham James A; Fearn Paul; Scher Howard I; Kelly Kevin W; Chen Hui-Ni; Schöder Heiko; Hricak Hedvig; Scardino Peter T; Kattan Michael W
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1962-8.
2005: Zakian Kristen L; Sircar Kanishka; Hricak Hedvig; Chen Hui-Ni; Shukla-Dave Amita; Eberhardt Steven; Muruganandham Manickam; Ebora Lanie; Kattan Michael W; Reuter Victor E; Scardino Peter T; Koutcher Jason A
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
Radiology 2005;234(3):804-14.
2005: Haese Alexander; Vaisanen Ville; Lilja Hans; Kattan Michael W; Rittenhouse Harry G; Pettersson Kim; Chan Daniel W; Huland Hartwig; Sokoll Lori J; Partin Alan W
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
The Journal of urology 2005;173(3):752-6.
2005: Carver Brett S; Kattan Michael W; Scardino Peter T; Eastham James A
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
BJU international 2005;95(4):509-12.
2005: Yanke Brent V; Gonen Mithat; Scardino Peter T; Kattan Michael W
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
The Journal of urology 2005;173(2):421-4.
2005: Peeters Koen C M J; Kattan Michael W; Hartgrink Henk H; Kranenbarg Elma Klein; Karpeh Martin S; Brennan Murray F; van de Velde Cornelis J H
Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.
Cancer 2005;103(4):702-7.
2005: Sorbellini Maximiliano; Kattan Michael W; Snyder Mark E; Reuter Victor; Motzer Robert; Goetzl Manlio; McKiernan James; Russo Paul
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
The Journal of urology 2005;173(1):48-51.
2005: Mariani Luigi; Miceli Rosalba; Kattan Michael W; Brennan Murray F; Colecchia Maurizio; Fiore Marco; Casali Paolo G; Gronchi Alessandro
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
Cancer 2005;103(2):402-8.
2004: Bach Peter B; Elkin Elena B; Pastorino Ugo; Kattan Michael W; Mushlin Alvin I; Begg Colin B; Parkin D Maxwell
Benchmarking lung cancer mortality rates in current and former smokers.
Chest 2004;126(6):1742-9.
2004: Mullerad Michael; Russo Paul; Golijanin Dragan; Chen Hui Ni; Tsai Harold H; Donat S Machele; Bochner Bernard H; Herr Harry W; Sheinfeld Joel; Sogani Pramod C; Kattan Michael W; Dalbagni Guido
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
The Journal of urology 2004;172(6 Pt 1):2177-81.
2004: Kattan Michael W; Giri Dilip; Panageas Katherine S; Hummer Amanda; Cranor Milicent; Van Zee Kimberly J; Hudis Clifford A; Norton Larry; Borgen Patrick I; Tan Lee K
A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.
Cancer 2004;101(11):2509-15.
2004: Carver Brett S; Bozeman Caleb B; Simoneaux Walter J; Venable Dennis D; Kattan Michael W; Eastham James A
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
The Journal of urology 2004;172(5 Pt 1):1853-5.
2004: Eilber Fritz C; Brennan Murray F; Eilber Frederick R; Dry Sarah M; Singer Samuel; Kattan Michael W
Validation of the postoperative nomogram for 12-year sarcoma-specific mortality.
Cancer 2004;101(10):2270-5.
2004: Bianco Fernando J; Kattan Michael W; Scardino Peter T
PSA velocity and prostate cancer.
The New England journal of medicine 2004;351(17):1800-2; author reply 1800-2.
2004: Bochner Bernard H; Cho Daniel; Herr Harry W; Donat Machele; Kattan Michael W; Dalbagni Guido
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
The Journal of urology 2004;172(4 Pt 1):1286-90.
2004: Secin Fernando P; Carver Brett; Kattan Michael W; Eastham James A
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate?
Transplantation 2004;78(5):710-2.
2004: Elkin Elena B; Cowen Mark E; Cahill Daniel; Steffel Mary; Kattan Michael W
Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
Medical decision making : an international journal of the Society for Medical Decision Making 2004;24(5):504-10.
2004: Brennan Murray F; Kattan Michael W; Klimstra David; Conlon Kevin
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas.
Annals of surgery 2004;240(2):293-8.
2004: Karakiewicz Pierre I; Tanguay Simon; Kattan Michael W; Elhilali Mostafa M; Aprikian Armen G
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men.
European urology 2004;46(2):188-94.
2004: Kattan Michael W; Vickers Andrew J
Incorporating predictions of individual patient risk in clinical trials.
Urologic oncology 2004;22(4):348-52.
2004: Wang Liang; Mullerad Michael; Chen Hui-Ni; Eberhardt Steven C; Kattan Michael W; Scardino Peter T; Hricak Hedvig
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
Radiology 2004;232(1):133-9.
2004: Mullerad Michael; Hricak Hedvig; Wang Liang; Chen Hui-Ni; Kattan Michael W; Scardino Peter T
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.
Radiology 2004;232(1):140-6.
2004: Hricak Hedvig; Wang Liang; Wei David C; Coakley Fergus V; Akin Oguz; Reuter Victor E; Gonen Mithat; Kattan Michael W; Onyebuchi Chinyere N; Scardino Peter T
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
Cancer 2004;100(12):2655-63.
2004: Singh Herb; Karakiewicz Pierre; Shariat Shahrokh F; Canto Eduardo I; Nath Rahul K; Kattan Michael W; Slawin Kevin M
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
Urology 2004;63(6):1122-7.
2004: Greene Kirsten L; Meng Maxwell V; Elkin Eric P; Cooperberg Matthew R; Pasta David J; Kattan Michael W; Wallace Katrine; Carroll Peter R
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
The Journal of urology 2004;171(6 Pt 1):2255-9.
2004: Ohori Makoto; Kattan Michael W; Koh Hideshige; Maru Norio; Slawin Kevin M; Shariat Shahrokh; Muramoto Masatoshi; Reuter Victor E; Wheeler Thomas M; Scardino Peter T
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
The Journal of urology 2004;171(5):1844-9; discussion 1849.
2004: Boccon-Gibod L; Djavan W B; Hammerer P; Hoeltl W; Kattan M W; Prayer-Galetti T; Teillac P; Tunn U W
Management of prostate-specific antigen relapse in prostate cancer: a European Consensus.
International journal of clinical practice 2004;58(4):382-90.
2004: Potters Louis; Klein Eric A; Kattan Michael W; Reddy Chandana A; Ciezki Jay P; Reuther Alwyn M; Kupelian Patrick A
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;71(1):29-33.
2004: Shariat Shahrokh F; Kattan Michael W; Traxel Erica; Andrews Ben; Zhu Kuichun; Wheeler Thomas M; Slawin Kevin M
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1992-9.
2004: Stephenson Andrew J; Shariat Shahrokh F; Zelefsky Michael J; Kattan Michael W; Butler E Brian; Teh Bin S; Klein Eric A; Kupelian Patrick A; Roehrborn Claus G; Pistenmaa David A; Pacholke Heather D; Liauw Stanley L; Katz Matthew S; Leibel Steven A; Scardino Peter T; Slawin Kevin M
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
JAMA : the journal of the American Medical Association 2004;291(11):1325-32.
2004: Diblasio Christopher J; Snyder Mark E; Kattan Michael W; Russo Paul
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.
The Journal of urology 2004;171(3):1062-5.
2004: Ohori Makoto; Kattan Michael; Scardino Peter T; Wheeler Thomas M
Radical prostatectomy for carcinoma of the prostate.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(3):349-59.
2004: Kattan Michael W
Evaluating a new marker's predictive contribution.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):822-4.
2004: Scher Howard I; Eisenberger Mario; D'Amico Anthony V; Halabi Susan; Small Eric J; Morris Michael; Kattan Michael W; Roach Mack; Kantoff Philip; Pienta Kenneth J; Carducci Michael A; Agus David; Slovin Susan F; Heller Glenn; Kelly William Kevin; Lange Paul H; Petrylak Daniel; Berg William; Higano Celestra; Wilding George; Moul Judd W; Partin Alan N; Logothetis Christopher; Soule Howard R
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):537-56.
2004: Hu Jim C; Elkin Eric P; Pasta David J; Lubeck Deborah P; Kattan Michael W; Carroll Peter R; Litwin Mark S
Predicting quality of life after radical prostatectomy: results from CaPSURE.
The Journal of urology 2004;171(2 Pt 1):703-7; discussion 707-8.
2004: Cagiannos Ilias; Karakiewicz Pierre; Graefen Markus; Eastham James A; Ohori Makoto; Rabbani Farhang; Reuter Victor; Wheeler Thomas; Kupelian Patrick; Klein Eric; Huland Hartwig; Hammerer Peter G; Erbersdobler Andreas; Schroeder Fritz; Wildhagen Mark; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
The Journal of urology 2004;171(2 Pt 1):692-6.
2004: Richstone Lee; Scherr Douglas S; Reuter Victor R; Snyder Mark E; Rabbani Farhang; Kattan Michael W; Russo Paul
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.
The Journal of urology 2004;171(2 Pt 1):615-20.
2004: Beck Stephen D W; Patel Manish I; Snyder Mark E; Kattan Michael W; Motzer Robert J; Reuter Victor E; Russo Paul
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Annals of surgical oncology 2004;11(1):71-7.
2004: Graefen Markus; Ohori Makoto; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Henke Rolf-Peter; Huland Hartwig; Wheeler Thomas M; Slawin Kevin; Scardino Peter T; Kattan Michael W
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
The Journal of urology 2004;171(1):200-3.
2004: Slawin Kevin M; Kattan Michael W
The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.
Reviews in urology 2004;6 Suppl 9():S40-5.
2004: Slawin Kevin M; Diblasio Christopher J; Kattan Michael W
Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
Reviews in urology 2004;6 Suppl 4():S3-8.
2004: Shariat Shahrokh F; Canto Eduardo I; Kattan Michael W; Slawin Kevin M
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.
Reviews in urology 2004;6(2):58-72.
2003: Diblasio Christopher J; Kattan Michael W
Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer.
Urology 2003;62 Suppl 1():9-18.
2003: Kattan Michael W
Comparing treatment outcomes using utility assessment for health-related quality of life.
Oncology (Williston Park, N.Y.) 2003;17(12):1687-93; discussion 1693-4, 1697, 1701.
2003: Kattan Michael W; Zelefsky Michael J; Kupelian Patrick A; Cho Daniel; Scardino Peter T; Fuks Zvi; Leibel Steven A
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4568-71.
2003: Potters Louis; Huang David; Calugaru Emel; Fearn Paul; Lee Lucille; Kattan Michael W
Importance of implant dosimetry for patients undergoing prostate brachytherapy.
Urology 2003;62(6):1073-7.
2003: Van Zee Kimberly J; Manasseh Donna-Marie E; Bevilacqua Jose L B; Boolbol Susan K; Fey Jane V; Tan Lee K; Borgen Patrick I; Cody Hiram S; Kattan Michael W
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Annals of surgical oncology 2003;10(10):1140-51.
2003: Eastham James A; Kattan Michael W; Riedel Elyn; Begg Colin B; Wheeler Thomas M; Gerigk Claudia; Gonen Mithat; Reuter Victor; Scardino Peter T
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 2003;170(6 Pt 1):2292-5.
2003: Kattan Michael W
Comparison of Cox regression with other methods for determining prediction models and nomograms.
The Journal of urology 2003;170(6 Pt 2):S6-9; discussion S10.
2003: Carroll Peter R; Benaron David A; Blackledge George; Coakley Fergus V; D'Amico Anthony V; Higano Celestia S; Iversen Peter; Kattan Michael; Nanus David M; Nelson Joel B; Oh William K; Roach Mack; Sellers William R; Smith Matthew R; McMann Mary Carole; Kantoff Philip W
Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
The Journal of urology 2003;170(6 Pt 2):S3-5.
2003: Littenberg Benjamin; Partilo Steven; Licata Anita; Kattan Michael W M
Paper Standard Gamble: the reliability of a paper questionnaire to assess utility.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(6):480-8.
2003: Kattan Michael W; Heller Glenn; Brennan Murray F
A competing-risks nomogram for sarcoma-specific death following local recurrence.
Statistics in medicine 2003;22(22):3515-25.
2003: Solit David B; Morris Michael; Slovin Susan; Curley Tracy; Schwartz Lawrence; Larson Steven; Kattan Michael W; Hartley-Asp Beryl; Scher Howard I; Kelly W Kevin
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
Cancer 2003;98(9):1842-8.
2003: Cagiannos Ilias; Karakiewicz Pierre; Eastham James A; Ohori Makato; Rabbani Farhang; Gerigk Claudia; Reuter Victor; Graefen Markus; Hammerer Peter G; Erbersdobler Andreas; Huland Hartwig; Kupelian Patrick; Klein Eric; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Morash Christopher G; Scardino Peter T; Kattan Michael W
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
The Journal of urology 2003;170(5):1798-803.
2003: Kattan Michael W; Eastham James A; Wheeler Thomas M; Maru Norio; Scardino Peter T; Erbersdobler Andreas; Graefen Markus; Huland Hartwig; Koh Hideshige; Shariat Shahrokh F; Slawin Kevin M; Ohori Makoto
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
The Journal of urology 2003;170(5):1792-7.
2003: Di Blasio Christopher J; Rhee Audrey C; Cho Daniel; Scardino Peter T; Kattan Michael W
Predicting clinical end points: treatment nomograms in prostate cancer.
Seminars in oncology 2003;30(5):567-86.
2003: Kattan Michael W; Karpeh Martin S; Mazumdar Madhu; Brennan Murray F
Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3647-50.
2003: Koh Hideshige; Kattan Michael W; Scardino Peter T; Suyama Kazuho; Maru Norio; Slawin Kevin; Wheeler Thomas M; Ohori Makoto
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.
The Journal of urology 2003;170(4 Pt 1):1203-8.
2003: Lopez-Corona Ernesto; Ohori Makoto; Scardino Peter T; Reuter Victor E; Gonen Mithat; Kattan Michael W
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.
The Journal of urology 2003;170(4 Pt 1):1184-8; discussion 1188.
2003: Zakian Kristen L; Eberhardt Steven; Hricak Hedvig; Shukla-Dave Amita; Kleinman Shanon; Muruganandham Manickam; Sircar Kanishka; Kattan Michael W; Reuter Victor E; Scardino Peter T; Koutcher Jason A
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
Radiology 2003;229(1):241-7.
2003: Kattan Michael W; Shariat Shahrokh F; Andrews Ben; Zhu Kuichun; Canto Eduardo; Matsumoto Kazumasa; Muramoto Masatoshi; Scardino Peter T; Ohori Makoto; Wheeler Thomas M; Slawin Kevin M
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3573-9.
2003: Shariat Shahrokh F; Kattan Michael W; Song Weitao; Bernard David; Gottenger Emanuel; Wheeler Thomas M; Slawin Kevin M
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
Cancer research 2003;63(18):5874-8.
2003: Shariat Shahrokh F; Roudier Martine P; Wilcox George E; Kattan Michael W; Scardino Peter T; Vessella Robert L; Erdamar Sibel; Nguyen Cuong; Wheeler Thomas M; Slawin Kevin M
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
Cancer research 2003;63(15):4662-70.
2003: Potters Louis; Kattan Michael W; Fearn Paul
A chronological database to support outcomes research in prostate cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1252-8.
2003: Cho Daniel; Di Blasio Christopher J; Rhee Audrey C; Kattan Michael W
Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT).
Urologic oncology 2003;21(4):282-91.
2003: Aleman Michael; Karakiewicz Pierre I; Kupelian Patrick; Kattan Michael W; Graefen Markus; Cagiannos Ilias; Eastham James; Scardino Peter T; Huland Hartwig; Klein Eric A
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
Urology 2003;62(1):70-4.
2003: Bianco Fernando J; Kattan Michael W; Scardino Peter T; Powell Isaac J; Pontes J Edson; Wood David P
Radical prostatectomy nomograms in black American men: accuracy and applicability.
The Journal of urology 2003;170(1):73-6; discussion 76-7.
2003: Potters Louis; Purrazzella Rosemary; Brustein Sheryl; Fearn Paul; Huang David; Leibel Steven A; Kattan Michael W
The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;56(3):749-54.
2003: Yossepowitch Ofer; Trabulsi Edouard J; Kattan Michael W; Scardino Peter T
Predictive factors in prostate cancer: implications for decision making.
Cancer investigation 2003;21(3):465-80.
2003: Lee Cheryl T; Genega Elizabeth M; Hutchinson Brian; Fearn Paul A; Kattan Michael W; Russo Paul; Reuter Victor E
Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
Urologic oncology 2003;21(3):179-84.
2003: Graefen M; Augustin H; Karakiewicz P I; Hammerer P G; Haese A; Palisaar J; Fernandez S; Noldus J; Erbersdobler A; Cagiannos I; Scardino P T; Kattan M W; Huland H
[Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]
Der Urologe. Ausg. A 2003;42(5):685-92.
2003: Patel Manish I; Simmons Rachel; Kattan Michael W; Motzer Robert J; Reuter Victor E; Russo Paul
Long-term follow-up of bilateral sporadic renal tumors.
Urology 2003;61(5):921-5.
2003: Swindle Peter W; Kattan Michael W; Scardino Peter T
Markers and meaning of primary treatment failure.
The Urologic clinics of North America 2003;30(2):377-401.
2003: Kattan Michael W
Judging new markers by their ability to improve predictive accuracy.
Journal of the National Cancer Institute 2003;95(9):634-5.
2003: Halabi Susan; Small Eric J; Kantoff Philip W; Kattan Michael W; Kaplan Ellen B; Dawson Nancy A; Levine Ellis G; Blumenstein Brent A; Vogelzang Nicholas J
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1232-7.
2003: Shariat Shahrokh F; Kattan Michael W; Erdamar Sibel; Nguyen Cuong; Scardino Peter T; Spencer David M; Wheeler Thomas M; Slawin Kevin M
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1223-31.
2003: Kattan Michael W; Eastham James
Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer.
Clinical prostate cancer 2003;1(4):221-6.
2003: Bach Peter B; Kattan Michael W; Thornquist Mark D; Kris Mark G; Tate Ramsey C; Barnett Matt J; Hsieh Lillian J; Begg Colin B
Variations in lung cancer risk among smokers.
Journal of the National Cancer Institute 2003;95(6):470-8.
2003: Kattan Michael W
Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer.
Current opinion in urology 2003;13(2):111-6.
2003: Ohori Makoto; Kattan Michael W; Utsunomiya Takuji; Suyama Kazuho; Scardino Peter T; Wheeler Thomas M
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?
The Journal of urology 2003;169(3):964-8.
2003: Karakiewicz Pierre I; Kattan Michael W; Tanguay Simon; Elhilali Mostafa M; Bazinet Michel; Scardino Peter T; Aprikian Armen G
Cross-cultural validation of the UCLA prostate cancer index.
Urology 2003;61(2):302-7.
2003: Haese Alexander; Graefen Markus; Becker Charlotte; Noldus Joachin; Katz Jared; Cagiannos Ilias; Kattan Michael; Scardino Peter T; Huland Edith; Huland Hartwig; Lilja Hans
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
The Prostate 2003;54(3):181-6.
2003: Potters Louis; Huang David; Fearn Paul; Kattan Michael W
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
Brachytherapy 2003;2(1):26-31.
2003: Ross Phillip L; Littenberg Benjamin; Fearn Paul; Scardino Peter T; Karakiewicz Pierre I; Kattan Michael W
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
International journal of technology assessment in health care 2003;19(1):135-47.
2002: Knudsen Beatrice S; Gmyrek Glenn A; Inra Jennifer; Scherr Douglas S; Vaughan E Darracott; Nanus David M; Kattan Michael W; Gerald William L; Vande Woude George F
High expression of the Met receptor in prostate cancer metastasis to bone.
Urology 2002;60(6):1113-7.
2002: McKiernan James; Yossepowitch Ofer; Kattan Michael W; Simmons Rachel; Motzer Robert J; Reuter Victor E; Russo Paul
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.
Urology 2002;60(6):1003-9.
2002: Yossepowitch Ofer; Sircar Kanishka; Scardino Peter T; Ohori Makoto; Kattan Michael W; Wheeler Thomas M; Reuter Victor E
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
The Journal of urology 2002;168(5):2011-5.
2002: Shariat Shahrokh F; Gottenger Emanuel; Nguyen Cuong; Song Weitao; Kattan Michael W; Andenoro John; Wheeler Thomas M; Spencer David M; Slawin Kevin M
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
Cancer research 2002;62(20):5974-9.
2002: Smaletz Oren; Scher Howard I; Small Eric J; Verbel David A; McMillan Alex; Regan Kevin; Kelly W Kevin; Kattan Michael W
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(19):3972-82.
2002: Potters Louis; Purrazzella Rosemary; Brustein Sheryl; Fearn Paul; Leibel Steven A; Kattan Michael W
A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
Cancer 2002;95(7):1451-6.
2002: Knight Sara J; Nathan Derek P; Siston Amy K; Kattan Michael W; Elstein Arthur S; Collela Kathleen M; Wolf Michael S; Slimack Nicholas S; Bennett Charles L; Golub Robert M
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.
Clinical prostate cancer 2002;1(2):105-14.
2002: Kattan Michael W; Scardino Peter T
Prediction of progression: nomograms of clinical utility.
Clinical prostate cancer 2002;1(2):90-6.
2002: Coakley Fergus V; Eberhardt Steven; Kattan Michael W; Wei David C; Scardino Peter T; Hricak Hedvig
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.
The Journal of urology 2002;168(3):1032-5.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; Klein Eric; Kupelian Patrick; Skinner Donald G; Lieskovsky Gary; Bochner Bernard; Huland Hartwig; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Eastham James A; de Kernion Jean; Cangiano Thomas; Schröder Fritz H; Wildhagen Mark F; van der Kwast Theo H; Scardino Peter T; Kattan Michael W
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3206-12.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Fernandez Salvador; Noldus Jochen; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
Urologic oncology 2002;7(4):141-6.
2002: Lee Lucille N; Barnswell Carlton; Torre Taryn; Fearn Paul; Kattan Michael; Potters Louis
Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses.
International journal of radiation oncology, biology, physics 2002;53(2):282-9.
2002: Kattan Michael W
Nomograms. Introduction.
Seminars in urologic oncology 2002;20(2):79-81.
2002: Eastham James A; Kattan Michael W; Scardino Peter T
Nomograms as predictive models.
Seminars in urologic oncology 2002;20(2):108-15.
2002: Ross Phillip L; Gerigk Claudia; Gonen Mithat; Yossepowitch Ofer; Cagiannos Ilias; Sogani Pramod C; Scardino Peter T; Kattan Michael W
Comparisons of nomograms and urologists' predictions in prostate cancer.
Seminars in urologic oncology 2002;20(2):82-8.
2002: Cagiannos Ilias; Graefen Markus; Karakiewicz Pierre I; Ohori Makato; Eastham James A; Rabbani Farhang; Fair William; Wheeler Thomas M; Hammerer Peter G; Haese Alexander; Erbersdobler Andreas; Huland Hartwig; Scardino Peter T; Kattan Michael W
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2025-30.
2002: Begg Colin B; Riedel Elyn R; Bach Peter B; Kattan Michael W; Schrag Deborah; Warren Joan L; Scardino Peter T
Variations in morbidity after radical prostatectomy.
The New England journal of medicine 2002;346(15):1138-44.
2002: Eastham James A; Carver Brett; Katz Jared; Kattan Michael W
Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
The Prostate 2002;50(4):236-40.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Hammerer Peter G; Haese Alexander; Palisaar Jüri; Huland Edith; Scardino Peter T; Kattan Michael W; Huland Hartwig
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
The Journal of urology 2002;167(3):1306-9.
2002: Graefen Markus; Karakiewicz Pierre I; Cagiannos Ilias; Klein Eric; Kupelian Patrick A; Quinn David I; Henshall Susan M; Grygiel John J; Sutherland Robert L; Stricker Phillip D; de Kernion Jean; Cangiano Thomas; Schröder Fritz H; Wildhagen Mark F; Scardino Peter T; Kattan Michael W
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):951-6.
2002: Kattan Michael
Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic".
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):885-7.
2002: Shariat Shahrokh F; Lamb Dolores J; Kattan Michael W; Nguyen Cuong; Kim JaHong; Beck Josie; Wheeler Thomas M; Slawin Kevin M
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):833-41.
2002: Kattan Michael W; Leung Denis H Y; Brennan Murray F
Postoperative nomogram for 12-year sarcoma-specific death.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):791-6.
2002: Hull Gerald W; Rabbani Farhang; Abbas Farhat; Wheeler Thomas M; Kattan Michael W; Scardino Peter T
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.
The Journal of urology 2002;167(2 Pt 1):528-34.
2002: Slawin Kevin M; Canto Eduardo I; Shariat Shahrokh F; Gore John L; Kim Edward; Kattan Michael W; Wheeler Thomas M; Nath Rahul K
Sural Nerve Interposition Grafting during Radical Prostatectomy.
Reviews in urology 2002;4(1):17-23.
2002: Potters L; Fearn P; Kattan M
The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
Prostate cancer and prostatic diseases 2002;5(1):47-53.
2002: Potters Louis; Fearn Paul; Kattan Michael W
External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer.
Brachytherapy 2002;1(1):36-41.
2001: Shariat S F; Kim J H; Andrews B; Kattan M W; Wheeler T M; Kim I Y; Lerner S P; Slawin K M
Preoperative plasma levels of transforming growth factor beta(1) strongly predict clinical outcome in patients with bladder carcinoma.
Cancer 2001;92(12):2985-92.
2001: Shariat S F; Andrews B; Kattan M W; Kim J; Wheeler T M; Slawin K M
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.
Urology 2001;58(6):1008-15.
2001: Kothari P S; Scardino P T; Ohori M; Kattan M W; Wheeler T M
Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
The American journal of surgical pathology 2001;25(11):1429-32.
2001: Kattan M W; Potters L; Blasko J C; Beyer D C; Fearn P; Cavanagh W; Leibel S; Scardino P T
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.
Urology 2001;58(3):393-9.
2001: Maru N; Ohori M; Kattan M W; Scardino P T; Wheeler T M
Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Human pathology 2001;32(8):828-33.
2001: Potters L; Torre T; Fearn P A; Leibel S A; Kattan M W
Potency after permanent prostate brachytherapy for localized prostate cancer.
International journal of radiation oncology, biology, physics 2001;50(5):1235-42.
2001: Kattan M W; Reuter V; Motzer R J; Katz J; Russo P
A postoperative prognostic nomogram for renal cell carcinoma.
The Journal of urology 2001;166(1):63-7.
2001: Shariat S F; Shalev M; Menesses-Diaz A; Kim I Y; Kattan M W; Wheeler T M; Slawin K M
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(11):2856-64.
2001: Ross P L; Scardino P T; Kattan M W
A catalog of prostate cancer nomograms.
The Journal of urology 2001;165(5):1562-8.
2001: Byrne R R; Shariat S F; Brown R; Kattan M W; Morton RA J R; Wheeler T M; Lerner S P
E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
The Journal of urology 2001;165(5):1473-9.
2001: Herman C M; Kattan M W; Ohori M; Scardino P T; Wheeler T M
Primary Gleason pattern as a predictor of disease progression in gleason score 7 prostate cancer: a multivariate analysis of 823 men treated with radical prostatectomy.
The American journal of surgical pathology 2001;25(5):657-60.
2001: Leventis A K; Shariat S F; Kattan M W; Butler E B; Wheeler T M; Slawin K M
Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1030-9.
2001: Kattan M W; Fearn P A; Miles B J
Time trade-off utility modified to accommodate degenerative and life-threatening conditions.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 2001;():304-8.
2000: Slawin K M; Shariat S F; Nguyen C; Leventis A K; Song W; Kattan M W; Young C Y; Tindall D J; Wheeler T M
Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
Cancer research 2000;60(24):7142-8.
2000: Kattan M W; Fearn P A; Leibel S; Potters L
The definition of biochemical failure in patients treated with definitive radiotherapy.
International journal of radiation oncology, biology, physics 2000;48(5):1469-74.
2000: Rabbani F; Stapleton A M; Kattan M W; Wheeler T M; Scardino P T
Factors predicting recovery of erections after radical prostatectomy.
The Journal of urology 2000;164(6):1929-34.
2000: Blute M L; Bergstralh E J; Partin A W; Walsh P C; Kattan M W; Scardino P T; Montie J E; Pearson J D; Slezak J M; Zincke H
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Cantor S B; Kattan M W
Determining the area under the ROC curve for a binary diagnostic test.
Medical decision making : an international journal of the Society for Medical Decision Making 2000;20(4):468-70.
2000: Kattan M W; Zelefsky M J; Kupelian P A; Scardino P T; Fuks Z; Leibel S A
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3352-9.
2000: Sutton M A; Freund C T; Berkman S A; Dang T D; Kattan M W; Wheeler T M; Rowley D R; Lerner S P
In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;2(3):211-7.
2000: Shariat S F; Bergamaschi F; Adler H L; Nguyen C; Kattan M W; Wheeler T M; Slawin K M
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.
Urology 2000;56(3):423-9.
2000: Zupan B; Demsar J; Kattan M W; Beck J R; Bratko I
Machine learning for survival analysis: a case study on recurrence of prostate cancer.
Artificial intelligence in medicine 2000;20(1):59-75.
2000: Herman C M; Wilcox G E; Kattan M W; Scardino P T; Wheeler T M
Lymphovascular invasion as a predictor of disease progression in prostate cancer.
The American journal of surgical pathology 2000;24(6):859-63.
2000: Blutt S E; Polek T C; Stewart L V; Kattan M W; Weigel N L
A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
Cancer research 2000;60(4):779-82.
2000: Eastham J A; Kattan M W
Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
The Journal of urology 2000;163(1):143-5.
2000: Giesler R B; Miles B J; Cowen M E; Kattan M W
Assessing quality of life in men with clinically localized prostate cancer: development of a new instrument for use in multiple settings.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2000;9(6):645-65.
1999: Witte M N; Kattan M W; Albani J; Sharp D S; Eastham J A; Morton R A
Race is not an independent predictor of positive surgical margins after radical prostatectomy.
Urology 1999;54(5):869-74.
1999: Eastham J A; May R; Robertson J L; Sartor O; Kattan M W
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.
Urology 1999;54(4):709-13.
1999: Erdamar S; Yang G; Harper J W; Lu X; Kattan M W; Thompson T C; Wheeler T M
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(8):751-5.
1999: Anton R C; Kattan M W; Chakraborty S; Wheeler T M
Postatrophic hyperplasia of the prostate: lack of association with prostate cancer.
The American journal of surgical pathology 1999;23(8):932-6.
1999: Kattan M W; Wheeler T M; Scardino P T
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1499-507.
1999: Kubricht W S; Kattan M W; Sartor O; Eastham J A
Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.
Urology 1999;53(3):553-6.
1999: Ohori M; Abbas F; Wheeler T M; Kattan M W; Scardino P T; Lerner S P
Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.
The Journal of urology 1999;161(2):500-4.
1999: Adler H L; McCurdy M A; Kattan M W; Timme T L; Scardino P T; Thompson T C
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
The Journal of urology 1999;161(1):182-7.
1999: Miles B J; Giesler B; Kattan M W
Recall and attitudes in patients with prostate cancer.
Urology 1999;53(1):169-74.
1999: Demsar J; Zupan B; Kattan M W; Beck J R; Bratko I
Naive Bayesian-based nomogram for prediction of prostate cancer recurrence.
Studies in health technology and informatics 1999;68():436-41.
1999: Kattan M W; Fearn P A; Cantor S B; Hu J; Cowen M E; Giesler R B; Miles B J
Telephone interviews vs. workstation sessions for acquiring quality of life data.
Proceedings / AMIA ... Annual Symposium. AMIA Symposium 1999;():296-300.
1998: Hu J C; Palapattu G S; Kattan M W; Scardino P T; Wheeler T M
The association of selected pathological features with prostate cancer in a single-needle biopsy accession.
Human pathology 1998;29(12):1536-8.
1998: Cowen M E; Miles B J; Cahill D F; Giesler R B; Beck J R; Kattan M W
The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients.
Medical decision making : an international journal of the Society for Medical Decision Making 1998;18(4):376-80.
1998: Kattan M W; Hess K R; Beck J R
Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression.
Computers and biomedical research, an international journal 1998;31(5):363-73.
1998: Yang G; Truong L D; Timme T L; Ren C; Wheeler T M; Park S H; Nasu Y; Bangma C H; Kattan M W; Scardino P T; Thompson T C
Elevated expression of caveolin is associated with prostate and breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(8):1873-80.
1998: Wheeler T M; Dillioglugil O; Kattan M W; Arakawa A; Soh S; Suyama K; Ohori M; Scardino P T
Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1-2 prostate cancer.
Human pathology 1998;29(8):856-62.
1998: Leibman B D; Dillioglugil O; Abbas F; Tanli S; Kattan M W; Scardino P T
Impact of a clinical pathway for radical retropubic prostatectomy.
Urology 1998;52(1):94-9.
1998: Leibman B D; Dillioglugil O; Scardino P T; Abbas F; Rogers E; Wolfinger R D; Kattan M W
Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2267-71.
1998: Hampel O Z; Kattan M W; Yang G; Haidacher S J; Saleh G Y; Thompson T C; Wheeler T M; Marcelli M
Quantitative immunohistochemical analysis of insulin-like growth factor binding protein-3 in human prostatic adenocarcinoma: a prognostic study.
The Journal of urology 1998;159(6):2220-5.
1998: Kattan M W; Eastham J A; Stapleton A M; Wheeler T M; Scardino P T
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.
Journal of the National Cancer Institute 1998;90(10):766-71.
1998: Kim Y H; Goodman C; Omessi E; Rivera V; Kattan M W; Boone T B
The correlation of urodynamic findings with cranial magnetic resonance imaging findings in multiple sclerosis.
The Journal of urology 1998;159(3):972-6.
1998: Kim Y H; Kattan M W; Boone T B
Bladder leak point pressure: the measure for sphincterotomy success in spinal cord injured patients with external detrusor-sphincter dyssynergia.
The Journal of urology 1998;159(2):493-6; discussion 496-7.
1998: Stapleton A M; Zbell P; Kattan M W; Yang G; Wheeler T M; Scardino P T; Thompson T C
Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery.
Cancer 1998;82(1):168-75.
1997: Kim Y H; Kattan M W; Boone T B
Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection.
Urology 1997;50(6):941-8.
1997: Gingrich J R; Barrios R J; Kattan M W; Nahm H S; Finegold M J; Greenberg N M
Androgen-independent prostate cancer progression in the TRAMP model.
Cancer research 1997;57(21):4687-91.
1997: Eastham J A; Kattan M W; Groshen S; Scardino P T; Rogers E; Carlton C E; Lerner S P
Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(10):3214-22.
1997: Stapleton A M; Timme T L; Gousse A E; Li Q F; Tobon A A; Kattan M W; Slawin K M; Wheeler T M; Scardino P T; Thompson T C
Primary human prostate cancer cells harboring p53 mutations are clonally expanded in metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1389-97.
1997: Dillioglugil O; Leibman B D; Kattan M W; Seale-Hawkins C; Wheeler T M; Scardino P T
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.
Urology 1997;50(1):93-9.
1997: Soh S; Kattan M W; Berkman S; Wheeler T M; Scardino P T
Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy?
The Journal of urology 1997;157(6):2212-8.
1997: Kattan M W; Cowen M E; Miles B J
A decision analysis for treatment of clinically localized prostate cancer.
Journal of general internal medicine 1997;12(5):299-305.
1997: Partin A W; Kattan M W; Subong E N; Walsh P C; Wojno K J; Oesterling J E; Scardino P T; Pearson J D
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
JAMA : the journal of the American Medical Association 1997;277(18):1445-51.
1997: Dillioglugil O; Leibman B D; Leibman N S; Kattan M W; Rosas A L; Scardino P T
Risk factors for complications and morbidity after radical retropubic prostatectomy.
The Journal of urology 1997;157(5):1760-7.
1997: Sutton M A; Berkman S A; Chen S H; Block A; Dang T D; Kattan M W; Wheeler T M; Rowley D R; Woo S L; Lerner S P
Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
Urology 1997;49(2):173-80.
1997: Kattan M W; Stapleton A M; Wheeler T M; Scardino P T
Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma.
Cancer 1997;79(3):528-37.
1997: Henderson R J; Eastham J A; Culkin D J; Kattan M W; Whatley T; Mata J; Venable D; Sartor O
Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
Journal of the National Cancer Institute 1997;89(2):134-8.
1996: Marley G M; Miller M C; Kattan M W; Zhao G; Patton K P; Vessella R L; Wright G L; Schellhammer P F; Veltri R W
Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia.
Urology 1996;48(6A Suppl):16-22.
1996: Cowen M E; Kattan M W; Miles B J
A national survey of attitudes regarding participation in prostate carcinoma testing.
Cancer 1996;78(9):1952-7.
1996: Eastham J A; Kattan M W; Rogers E; Goad J R; Ohori M; Boone T B; Scardino P T
Risk factors for urinary incontinence after radical prostatectomy.
The Journal of urology 1996;156(5):1707-13.
1996: Kattan M W; Inoue Y; Giles F J; Talpaz M; Ozer H; Guilhot F; Zuffa E; Huber S L; Beck J R
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.
Annals of internal medicine 1996;125(7):541-8.
1996: Rogers E; Gürpinar T; Dillioglugil O; Kattan M W; Goad J R; Scardino P T; Griffith D P
The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
British journal of urology 1996;78(3):419-25.
1996: Yang G; Wheeler T M; Kattan M W; Scardino P T; Thompson T C
Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
Cancer 1996;78(6):1267-71.
1996: Goto Y; Ohori M; Arakawa A; Kattan M W; Wheeler T M; Scardino P T
Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies.
The Journal of urology 1996;156(3):1059-63.
1996: Kattan M W; Cowen M E; Miles B J
Computer modeling in urology.
Urology 1996;47(1):14-21.
1996: Cowen M E; Kattan M W; Miles B J
Survival and conservative treatment for localized prostate cancer.
JAMA : the journal of the American Medical Association 1996;275(1):31-2.
1996: Gürpinar T; Gürer S; Kattan M W; Wang L; Griffith D P
Laser-welded ureteral anastomoses: experimental studies with three techniques.
Techniques in urology 1996;2(2):117-20.
1995: Goad J R; Eastham J A; Fitzgerald K B; Kattan M W; Collini M P; Yawn D H; Scardino P T
Radical retropubic prostatectomy: limited benefit of autologous blood donation.
The Journal of urology 1995;154(6):2103-9.
1995: Ohori M; Wheeler T M; Kattan M W; Goto Y; Scardino P T
Prognostic significance of positive surgical margins in radical prostatectomy specimens.
The Journal of urology 1995;154(5):1818-24.
1995: Eastham J A; Truong L D; Rogers E; Kattan M; Flanders K C; Scardino P T; Thompson T C
Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Laboratory investigation; a journal of technical methods and pathology 1995;73(5):628-35.
1995: Kattan M W; Beck J R
Artificial neural networks for medical classification decisions.
Archives of pathology & laboratory medicine 1995;119(8):672-7.
1995: Miles B J; Kattan M W
Computer modeling of prostate cancer treatment. A paradigm for oncologic management?
Surgical oncology clinics of North America 1995;4(2):361-72.
1995: Miles B J; Kattan M W; Giesler R B; Cowen M
Screening for prostate cancer.
JAMA : the journal of the American Medical Association 1995;273(15):1173-4; author reply 1175-6.
1994: Beck J R; Kattan M W; Miles B J
A critique of the decision analysis for clinically localized prostate cancer.
The Journal of urology 1994;152(5 Pt 2):1894-9.
1994: Kattan M W; Adams D A
Explaining information technology use with the usefulness scale: a comparison with user age.
Proceedings / the ... Annual Symposium on Computer Application [sic] in Medical Care. Symposium on Computer Applications in Medical Care 1994;():81-5.
1993: Liang J C; Bailey N M; Gabriel G J; Kattan M W; Wang R Y; Hagemeister F B; Cabanillas F F; Fuller L M
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicity.
Leukemia & lymphoma 1993;9(6):503-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michael Kattan

Research Profile (preview)

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Physiology

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michael Kattan (preview)

All Publications